Safety and Effectiveness of Combination Rituximab and Cyclophosphamide Therapy for Treating Pediatric Patients With Severe Manifestations of Rheumatic Disease is a research paper published in ACR Open Rheumatology (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: T32 AR 069516
Arthritis Foundation
Grant: 344848.01.01.2024365.10
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: K23‐AR‐081410
National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH
Grant: K23-AR-081410
NIAMS NIH HHS
Grant: K23 AR081410
National Institutes of Health
Grant: 5K23AR081410-02
Developing a tool to support shared decision making in JIA between adolescents, parents, and providers
National Institutes of Health
Grant: 5T32AR069516-08
Training Program in Rheumatic and Musculoskeletal Diseases Research
FWCI
1.69
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords